pharmaceuticals
pharmaceuticals Articles
Agio Pharmaceuticals saw its shares sink on Monday after the firm announced results from its midstage trial for the treatment of relapsed or refractory acute myeloid leukemia.
Published:
Last Updated:
Clovis Oncology saw its shares make a handy gain in Wednesday’s session after the company priced its secondary offering.
Published:
Last Updated:
Neos Therapeutics saw its shares dip on Tuesday even thought it received approval from the FDA for its treatment of ADHD.
Published:
Last Updated:
Dova Pharmaceuticals intends to price its about 4 million shares in the range of $15 to $17 in an initial offering valued up to more than $79 million.
Published:
Last Updated:
Akcea Therapeutics expects to price more than 9 million shares in the range of $12 to $14 apiece in an initial public offering valued up to almost $155 million.
Published:
Last Updated:
Rigel Pharmaceuticals watched its shares make a handy uptick on Monday after the FDA approved its New Drug Application for the use of Tavalisse in patients with chronic or persistent immune...
Published:
Last Updated:
Clovis Oncology saw its shares make a massive gain early on Monday after the company announced top-line data from its confirmatory Phase 3 trial of its treatment of ovarian cancer.
Published:
Last Updated:
Shares of Aurinia Pharmaceuticals saw a handy gain on Friday after the firm presented new data from its mid-stage study in lupus nephritis during the Annual European Congress of Rheumatology.
Published:
Last Updated:
Mersana Therapeutics expects to price its 5 million shares in the range of $14 to $16 apiece in an initial public offering valued up to $92 million.
Published:
Last Updated:
Acceleron Pharma saw its shares droop early on Tuesday after the firm offered an update from its mid-stage trial in advanced renal cell carcinoma.
Published:
Last Updated:
A series of new reports from Jefferies focus on some of the top stocks in the pharmaceutical and biotech arenas. Almost all these stocks have data that could send shares measurably higher.
Published:
Last Updated:
The May 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Dova Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
In an unprecendented move, the U.S. Food and Drug administration (FDA) requested that Endo International remove its Opana ER from the market. Ultimately, the agency held concerns about abuse...
Published:
Last Updated:
In an unprecedented move, the FDA has requested that Endo International remove its opioid pain medication from the market. The agency now believes that the benefits of the drug may no longer outweigh...
Published:
Last Updated: